Revolo Biotherapeutics to Participate in the Sachs Associates 22nd Annual Biotech in Europe Forum for Global Partnering and ...
NEW ORLEANS and LONDON, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics ("Revolo" or the "Company"), a company developing therapies that reset the immune system to achieve superior long-term remission for patients with …